FDA Recall of Medline Medical Convenience Kits Due to Syringe Risk
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP is recalling 82 medical convenience kits because of a potential risk that the syringe rotating adaptor may unwind, leading to loose connections or disconnections.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 23, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Medline Industries, LP has initiated a recall due to a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
Which Products Are Affected
The affected products are Medline medical convenience kits containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes, specifically: 1. SHOULDER ARTHROSCOPY PACK, Medline SKU # DYNJ30880M, with UDI/DI each 10198459446207, UDI/DI case 40198459446208, and Lot Number 25LMJ532; 2. EXTREMITY PACK, Medline SKU # DYNJ64295A, with UDI/DI each 10193489353853, UDI/DI case 40193489353854, and Lot Number 24KMI274. A total of 82 kits are affected, distributed worldwide, including the United States nationwide, Puerto Rico, and countries such as Canada, Netherlands, Australia, Korea, Republic of, Sri Lanka, Pakistan, Japan, United Arab Emirates, Singapore, and Slovakia. The recall number is Z-1730-2026.
What You Should Do
Consumers should follow the firm's initial notification, which may include email, fax, letter, press release, telephone, or a visit, to get instructions on the recall from Medline Industries, LP.
Why This Matters
This recall involves medical devices classified as Class I, indicating a reasonable probability of serious adverse health consequences, highlighting the importance of ensuring safe medical equipment to prevent potential risks during procedures.
Source
Attribution: FDA recall notice Z-1730-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,519 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 23, 2026.
Frequently Asked Questions
Common questions about this FDA recall.